CASE REPORT
Acute heart failure with left ventricular thrombus in the course of eosinophilic granulomatosis with polyangiitis
More details
Hide details
Submission date: 2014-03-18
Final revision date: 2014-06-10
Acceptance date: 2014-06-23
Online publication date: 2014-07-31
Publication date: 2014-06-30
Reumatologia 2014;52(3):207-212
KEYWORDS
TOPICS
ABSTRACT
Eosinophilic granulomatosis with polyangiitis (EGPA) characterized by the coexistence of asthma, eosinophilia and characteristic histopathologic changes, is one of the primary systemic small vessel inflammation of unknown etiology. Cardiac involvement in the course of EGPA occur in 17–92% of patients affecting poor prognosis and acting major cause of mortality in this group of patients. EGPA should always be considered in the differential diagnosis of acute heart failure, especially in young patients with no risk factors for coronary heart disease, and in patients with the presence of asthma, allergic rhinitis or nasal polyps. A rare complication of cardiac involvement is the thrombus formation in the left ventricular apex requiring anticoagulation. We report a case of 49 year old man with cardiac involvement that mimic acute coronary syndrome and led to the diagnosis of EGPA.
REFERENCES (24)
1.
Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951; 27: 277-301. .
2.
Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-1100. .
3.
Lionaki S, Blyth ER, Hogan SL, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides. Arthritis Rheum 2012; 64: 3452-3462. .
4.
Rementol-Sintas M, Martinez-Valle F, Solans-Laqué R. Churg-Strauss Syndrome: An evolving paradigm. Autoimmunity Rev 2012; 12: 235-240. .
5.
Vagio A, Buzio C, Zwerina J. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy 2013; 68: 261-273. .
6.
Hrycek A, Pochopień-Kenig G, Wanat-Wiśniewska M i wsp. Opis przypadku zespołu Churga-Strauss. Wiad Lek 2006; 59: 117-121. .
7.
Pagnoux Ch, Guillevin L. Churg-Strauss syndrome: evidence for disease subtypes? Curr Opin Rheumatol 2010; 22: 21-28. .
8.
Pisarczyk-Wiza D, Wierusz-Wysocka B. Zespół Churga-Strauss: wyzwanie diagnostyczne i terapeutyczne – opis przypadku. Kardiol Pol 2009; 67: 410-414. .
9.
Vinit J, Bielefeld P, Muller G, et al. Heart involvement in Churg-Strauss syndrome: Retrospective study in French Burgundy population in past 10 years. Eur J Inter Med 2010; 21: 341-346. .
10.
Khoury P, Zagallo P, Talar-Williams C, et al. Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome. Allergy 2012; 67: 1149-1156. .
11.
Lanham JG, Elkon KB, Pussey CD, et al. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984; 63: 65-81. .
12.
Siemińska A. Zespół Churga-Strauss – rzadka choroba czy trudne rozpoznanie? Pneumonol Alergol Pol 2012; 80: 3-5. .
13.
Sinico RA, Di Toma L, Maggiore U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005; 52: 2926-2935. .
14.
Sable-Fourtassou R, Cohen P, Mahr A, et al. Antineutriphil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143: 632-638. .
15.
Sinico RA, Bottero P. Churg-Strauss angiitis. Best Pract Res Clin Rheumatol 2009; 23: 355-366. .
16.
Fijołek J, Wiatr E, Gawryluk D. i wsp. Podstawy rozpoznania zespołu Churga-Strauss w materiale własnym. Pneumonol Alergol Pol 2012; 80: 20-28. .
17.
Dennert RM, van Paassen P, Schalla S, et al. Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 2010; 62: 627-634. .
18.
Szczeklik W, Miszalski-Jamka T, Mastalerz L, et al. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J 2010; 75: 649-655. .
19.
Wita K, Kolasa J, Berger-Kucza A i wsp. Zespół Churga-Strauss z eozynofilowym zapaleniem mięśnia sercowego. Opis przypadku. Pol Przegl Kardiol 2006; 8: 443-446. .
20.
Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28. .
21.
Sokołowska B, Szczeklik W, Mastalerz L i wsp. Ciężka kardiomiopatia rozstrzeniowa jako powikłanie łagodnie przebiegającego zespołu Churga-Strauss. Kardiol Pol 2011; 69: 257-260. .
22.
Dropiński J, Szczeklik W, Sokołowska B. i wsp. Kardiomiopatia zastoinowa i skrzeplina w lewej komorze jako manifestacje zespołu Churga i Strauss. Kardiol Pol 2008; 66: 761-763. .
23.
Lipczyńska M, Klisiewicz A, Szymański P i wsp. Nie tylko po zawale serca – skrzeplina w lewej komorze w przebiegu zespołu Churga i Strauss. Kardiol Pol 2010; 68: 836-837. .
24.
Poręba M, Rostoff P, Konduracka E i wsp. Choroba endomiokardialna jako pierwsza manifestacja zespołu hipereozynofilowego. Kardiol Pol 2010; 68: 440-445.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.